CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

07 Aug 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

01 Aug 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

29 Jul 2024 23:00:00 By Nasdaq GlobeNewswire

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

29 Jul 2024 05:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

17 Jul 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Secures $20 Million Credit Facility

02 Jul 2024 04:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

01 Jul 2024 12:54:54 By NetDania Notify

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

28 Jun 2024 12:27:49 By NetDania Notify

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

24 Jun 2024 04:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

18 Jun 2024 12:27:17 By NetDania Notify

CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union

13 Jun 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

05 Jun 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

04 Jun 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Reports First Quarter 2024 Results

09 May 2024 13:17:23 By Nasdaq GlobeNewswire

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

02 May 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

26 Apr 2024 04:00:00 By Nasdaq GlobeNewswire

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

17 Apr 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

14 Mar 2024 13:39:31 By Nasdaq GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

06 Mar 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

08 Feb 2024 04:00:00 By Nasdaq GlobeNewswire